-go.jpg)
Get full access for you and your coworkers.
Start a free company trial todayAlready a member? Log in.
An internally-developed mobile app from Novo Nordisk will be part of a phase III trial involving the pharmaceutical company's grand hope insulin icodec. This app will help diabetes patients find their optimal insulin doses based on earlier doses and their blood sugar levels.
Already a member? Log in.